Back

Genetics to identify new drug targets in atrial fibrillation.

31 August 2019 (09:00 - 09:22)
Organised by:
Congress Presentation Part of: Horizons of discovery: using genetics to identify new drug targets Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Dobromir Dobrev

University Hospital of Essen (Ruhr), Essen (Germany)

3 More presentations in this session

Presentation thumbnail
Genetics to identify new drug targets in ischaemic heart disease.
Professor T. Kessler (Homburg, DE)
Presentation thumbnail
Genetics to identify new drug targets in stroke.
Professor M. Dichgans (Munich, DE)
Presentation thumbnail
Genetics to identify new drug targets in cardiomyopathy.
Doctor A. Marian (Houston, US)
Slides Video

Access the full session

Session thumbnail
Horizons of discovery: using genetics to identify new drug targets

The Event

Event poster

ESC Congress 2019

31 August 2019 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Genetic aspects associated with increased risk of developing atrial fibrillation
15 June 2024
thumbnail
Congress Session
EHRA Consensus Paper on Antiarrhythmic Drugs (AADs)
30 March 2025
thumbnail
Webinar
ACVC Biomarker Talk Series - Biomarkers in atrial fibrillation
24 November 2021
thumbnail
Congress Presentation
Unravelling the signaling pathway downstream of the neurokinin receptor in atrium: discovering novel anti-arrhythmic targets for treatment of atrial fibrillation
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources